text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 129-56-6 | Product Number: A2548

Anthra[1,9-cd]pyrazol-6(2H)-one


Purity: >95.0%(HPLC)
Chemical Substance Law (ENCS):   5-271
Synonyms:
  • Dibenzo[cd,g]indazol-6(2H)-one
  • SP 600125
Product Documents:
25MG
¥19,500
3   4   Contact Us
* Available Stock: Prompt shipment (for products) in Saitama/Hyogo warehouse. Stock In Other WH: Shipment in about 2-3 Business Days from Saitama warehouse. Please contact us if you need further information.
* The displayed price is the unit price and does not include consumption tax. The unit prices displayed are the latest and are subject to change without notice.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.

Product Number A2548
Purity / Analysis Method >95.0%(HPLC)
Molecular Formula / Molecular Weight C__1__4H__8N__2O = 220.23 
Physical State (20 deg.C) Solid
Storage Temperature Refrigerated (0-10°C)
Condition to Avoid Heat Sensitive
Packaging and Container 25MG-Glass Bottle with Plastic Insert (View image)
CAS RN 129-56-6
Reaxys Registry Number 746890
PubChem Substance ID 253659651
MDL Number

MFCD00022289

Specifications
Appearance Light yellow to Yellow to Green powder to crystal
Purity(HPLC) min. 95.0 area%
Properties (reference)
Melting Point 282 °C
GHS
Related Laws:
Chemical Substance Law (ENCS) 5-271
RTECS# CB4585000
Transport Information:
Application
LRRK2 Inhibitory Effect of SP600125

This product (SP600125) is an inhibitor of Jun N-terminal kinase (JNK), which is a stress-activated protein kinase that can be induced by inflammatory cytokines, bacterial endotoxin, osmotic shock, UV radiation, and hypoxia. In addition, there is a report that SP600125 inhibits LRRK2 (Leucine-rich repeat kinase 2) -G2019S, which is a promising therapeutic target for the treatment of Parkinson's disease, in the low micro-molar range. (The product is for research purpose only.)

References


Application
Apoptosis

References


Application
c-Jun N-Terminal Kinase (JNK) Inhibitor

References


PubMed Literature


Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.